CN1247064A - Compound urea drops for ear - Google Patents
Compound urea drops for ear Download PDFInfo
- Publication number
- CN1247064A CN1247064A CN 99114254 CN99114254A CN1247064A CN 1247064 A CN1247064 A CN 1247064A CN 99114254 CN99114254 CN 99114254 CN 99114254 A CN99114254 A CN 99114254A CN 1247064 A CN1247064 A CN 1247064A
- Authority
- CN
- China
- Prior art keywords
- distilled water
- urea
- ear
- boric acid
- dexamethasone phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A compound urea ear drops for promoting growth of membrane tympani, antibacterial inflammation-relieving, and moistening is prepared through adding several medicines to distilled water, stirring sufficiently, adding glycerin, and adding distilled water enough. It features that said several medicines include boric acid, urea and dexamethasone phosphate. Its advantages are easy preparing and convenient application.
Description
The present invention relates to a kind of [, exactly is a kind of compound urea drops for ear that promotes the tympanum growth.
The dense property of chronicity otitis media is that very common frequently-occurring disease of hals,Nasen und Ohrenheilkunde and sickness rate are high.Long-term or intermittent flow is dense with in ear clinically, the perforation of ear drum, auditory dysesthesia are characteristics, therefore not only bring misery but also influence life, study and work to the patient, also can cause the inside and outside complication of serious cranium sometimes and the life security that jeopardizes patient.Treating this disease at first is that its inflammation is disappeared fully, remakes the tympanum reparation, can cure otitis media.Tympanum is repaiied film and is mostly adopted surgical repair in hospital at present, though can cure otitis media, surgical repair not only needs the medical care expenses of both expensive, and general expenses are 2500-3000 yuan at present, therefore the patient is difficult to bear, and the operation of being in hospital brings misery also to influence study and work to the patient.
The purpose of this invention is to provide a kind of have promote tympanum growth, anti-inflammation, moisture-keeping function, and modulation is simple, cheap, easy to use compound urea drops for ear.
The present invention is realized by following technical scheme.
The present invention adds number flavor medicine fully to stir in distilled water, make its dissolving back add glycerol, adds the capacity distilled water again and promptly is modulated into medicinal liquid, and it is characterized in that: number flavor medicated bag is drawn together: boric acid, urea element and dexamethasone phosphate.
Liquid formula is:
Boric acid 2-6%
The plain 3-7% of urea
Dexamethasone phosphate 0.1-0.4%
Glycerol 15-30%
Advantage of the present invention is to cooperate the otitis media patient to implement " needle-pricking therapy tympanic membrane repairing " effectively, after being found fault, it can promote tympanum growth effectively, anti-inflammation and preserving moisture, thus the patient need be in hospital, few in misery, cure otitis media under the few situation of change expense.The present invention simultaneously modulates simply, and is cheap, easy to use.
Clinical use, 478 ears perforation tympanum is cured, after finding fault for the first time, once drip compound urea drops for ear every night, observe after five days, 388 ear perforation rims promptly have red fibrous loop growth, and the perforation of matched group 20 ear drum membranes is once dripped 0.25% chlorine syphilis eye water after finding fault for the first time every night, observe after five days, 2 ear perforation rims have a little red fibrous loop growth, 18 ears, no significant change.The former promotes the effect of tympanum growth apparently higher than the latter, and X 2 test is shown: X
2=53.4 P＜0.01.
By the following examples, the present invention is done to describe further.
Embodiment 1:
Get 2g boric acid and put into 35-45 ℃ of distilled water, stirring makes it dissolve back adding 7g urea element, 0.1g dexamethasone phosphate fully, fully stirs, it is dissolved fully, add 15ml glycerol again, add the capacity distilled water, making its total amount is 100ml, and adjusting PH is that 4-8 promptly gets required medicinal liquid.The patient uses, every day early, evening each once, each 2, evident in efficacy.
Embodiment 2:
Get 6g boric acid and put into 35-45 ℃ of distilled water, stirring makes it dissolve back adding 3g urea element, 0.4g dexamethasone phosphate fully, fully stirs, it is dissolved fully, add 30ml glycerol again, add the capacity distilled water, making its total amount is 100ml, and adjusting PH is that 4-8 promptly gets required medicinal liquid.The patient uses, every day early, evening each once, each 2, evident in efficacy.
Embodiment 3:
Get 3g boric acid and put into 35-45 ℃ of distilled water, stirring makes it dissolve back adding 6g urea element, 0.3g dexamethasone phosphate fully, fully stirs, it is dissolved fully, add 25ml glycerol again, add the capacity distilled water, making its total amount is 100ml, and adjusting PH is that 4-8 promptly gets required medicinal liquid.The patient uses, every day early, evening each once, each 2, evident in efficacy.
Embodiment 4:
Get 4g boric acid and put into 35-45 ℃ of distilled water, stirring makes it dissolve back adding 5g urea element, 0.2g dexamethasone phosphate fully, fully stirs, it is dissolved fully, add 20ml glycerol again, add the capacity distilled water, making its total amount is 100ml, and adjusting PH is that 4-8 promptly gets required medicinal liquid.The patient uses, every day early, evening each once, each 2, evident in efficacy.
Embodiment 5:
Get 5g boric acid and put into 35-45 ℃ of distilled water, stirring makes it dissolve back adding 4g urea element, 0.1g dexamethasone phosphate fully, fully stirs, it is dissolved fully, add 25ml glycerol again, add the capacity distilled water, making its total amount is 100ml, and adjusting PH is that 4-8 promptly gets required medicinal liquid.The patient uses, every day early, evening each once, each 2, evident in efficacy.
Claims (2)
1, a kind of compound urea drops for ear adds number flavor medicine and fully stirs in distilled water, make its dissolving back add glycerol, adds the capacity distilled water again and promptly is modulated into medicinal liquid, and it is characterized in that: number flavor medicated bag is drawn together: boric acid, urea element and dexamethasone phosphate.
2, compound urea drops for ear according to claim 1 is characterized in that: described liquid formula is:
Boric acid 2-6%
The plain 3-7% of urea
Dexamethasone phosphate 0.1-0.4%
Glycerol 15-30%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114254A CN1098081C (en) | 1999-06-09 | 1999-06-09 | Compound urea drops for ear |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99114254A CN1098081C (en) | 1999-06-09 | 1999-06-09 | Compound urea drops for ear |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1247064A true CN1247064A (en) | 2000-03-15 |
| CN1098081C CN1098081C (en) | 2003-01-08 |
Family
ID=5277360
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99114254A Expired - Fee Related CN1098081C (en) | 1999-06-09 | 1999-06-09 | Compound urea drops for ear |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1098081C (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1062148C (en) * | 1996-03-29 | 2001-02-21 | 王继德 | Compound jiabing ear drops and preparation method thereof |
| CN1079244C (en) * | 1997-08-29 | 2002-02-20 | 李凯堂 | Medicine for abstaining from drugs and its preparation |
-
1999
- 1999-06-09 CN CN99114254A patent/CN1098081C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1098081C (en) | 2003-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5523093A (en) | Gels in the form of highly hydrated self-supporting film, the process for their preparation, and their use in the therapy of cutaneous lesions and/or pathologies | |
| CN102580166A (en) | Medical bionic transparent film implanting material, and preparation method and application of material | |
| CN102078639A (en) | Medicine carrying method of medical sponge | |
| CN109125799A (en) | GelMA hydrogel people takes off the preparation method of the three-dimensional double-deck auxiliary material of cell amnion | |
| CN109568634B (en) | Reduced graphene oxide antibacterial dressing and preparation method thereof | |
| Neely et al. | Diagnosis and treatment of spontaneous cerebrospinal fluid otorrhea | |
| CN113304304B (en) | Drug-loaded degradable and absorbable medical suture and preparation method thereof | |
| CN103083712A (en) | Stem cells or other bioactive substances doped surgical dressing | |
| RU2506913C2 (en) | Method of removing oroantral connection | |
| CN1247064A (en) | Compound urea drops for ear | |
| CN114288458A (en) | Bandage-fixing-free antibacterial anti-adhesion nanofiber dressing and preparation method thereof | |
| CN109550076B (en) | Medical silicone ozone oil vaseline dressing and wound care patch based on dressing | |
| RU2289411C1 (en) | Method for treatment of parodontitis of middle severity degree | |
| JP2002104974A (en) | Hydrogel therapeutic agent for damaged skin | |
| US20040249364A1 (en) | Device and method for dispensing medication to tissue lining a body cavity | |
| CN109908110A (en) | A kind of two-layer compound carries medicine adherency patch and its preparation method and application | |
| CN1247063A (en) | Ear drops | |
| Khan et al. | Management of dry socket using ozone gel vs. Alvogyl-prospective clinical trial | |
| WO2020211787A1 (en) | Pharmaceutical preparation, system comprising same, preparation method therefor and application thereof | |
| CN217696699U (en) | Postoperative hemostatic plaster for nasal cavity operation | |
| CN213310606U (en) | Bionic cancellous bone support for guiding regeneration of segmental defective bone of mandibular shaft | |
| CN212214029U (en) | Filler type wound pain relieving device | |
| Premana et al. | Malignant type of chronic suppurative otitis media with subperiosteal abscess complications: A case report | |
| ES2265272B1 (en) | COMPOSITION FOR THE TREATMENT OF WOUNDS. | |
| RU2264817C2 (en) | Method for treating mucosal diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |